A detailed history of Exodus Point Capital Management, LP transactions in Chroma Dex Corp. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 39,900 shares of CDXC stock, worth $272,118. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,900
Holding current value
$272,118
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.51 - $3.8 $100,148 - $151,620
39,900 New
39,900 $146,000
Q1 2024

May 14, 2024

BUY
$1.36 - $3.84 $28,464 - $80,371
20,930 New
20,930 $73,000
Q3 2021

Nov 15, 2021

SELL
$6.05 - $10.41 $77,391 - $133,164
-12,792 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$6.66 - $10.92 $133,046 - $218,148
-19,977 Reduced 60.96%
12,792 $126,000
Q1 2021

May 17, 2021

BUY
$4.59 - $18.74 $150,409 - $614,091
32,769 New
32,769 $306,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $466M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.